SPRY Insider Transactions — Page 3
340 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 201–300; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-05-16 | Sale | 44,746.0 | $9.06 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-05-16 | Sale | 44,350.0 | $9.06 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-05-16 | Sale | 44,746.0 | $9.06 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-05-15 | Sale | 2,766.0 | $9.04 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-05-15 | Sale | 2,381.0 | $9.05 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-05-15 | Sale | 2,766.0 | $9.04 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-05-15 | Sale | 2,381.0 | $9.05 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-05-14 | Sale | 2,884.0 | $9.01 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-05-14 | Sale | 2,873.0 | $9.01 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-05-14 | Sale | 2,884.0 | $9.01 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-05-14 | Sale | 2,873.0 | $9.01 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-05-07 | Sale | 50,000.0 | $9.34 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-05-07 | Sale | 50,000.0 | $9.34 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-05-07 | Sale | 50,000.0 | $9.34 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-05-07 | Sale | 50,000.0 | $9.34 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-04-16 | Sale | 50,000.0 | $9.28 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-04-16 | Sale | 50,000.0 | $9.28 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-04-16 | Sale | 50,000.0 | $9.28 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-04-16 | Sale | 50,000.0 | $9.28 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-04-09 | Sale | 50,000.0 | $9.28 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-04-09 | Sale | 50,000.0 | $9.28 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-04-09 | Sale | 50,000.0 | $9.28 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-04-09 | Sale | 50,000.0 | $9.28 |
| RA Capital Healthcare Fund LP | Director | 2024-03-27 | Purchase | 505,954.0 | $9.79 |
| RA CAPITAL MANAGEMENT, L.P. | Director,TenPercentOwner | 2024-03-27 | Purchase | 505,954.0 | $9.79 |
| Kolchinsky Peter | Director,TenPercentOwner | 2024-03-27 | Purchase | 505,954.0 | $9.79 |
| Shah Rajeev M. | Director,TenPercentOwner | 2024-03-27 | Purchase | 505,954.0 | $9.79 |
| RA Capital Nexus Fund II, L.P. | Director | 2024-03-27 | Purchase | 505,954.0 | $9.79 |
| RA Capital Healthcare Fund LP | Director | 2024-03-26 | Purchase | 457,745.0 | $9.55 |
| RA CAPITAL MANAGEMENT, L.P. | Director,TenPercentOwner | 2024-03-26 | Purchase | 457,745.0 | $9.55 |
| Kolchinsky Peter | Director,TenPercentOwner | 2024-03-26 | Purchase | 457,745.0 | $9.55 |
| Shah Rajeev M. | Director,TenPercentOwner | 2024-03-26 | Purchase | 457,745.0 | $9.55 |
| RA Capital Nexus Fund II, L.P. | Director | 2024-03-26 | Purchase | 457,745.0 | $9.55 |
| RA Capital Healthcare Fund LP | Director | 2024-03-25 | Purchase | 437,600.0 | $9.06 |
| RA CAPITAL MANAGEMENT, L.P. | Director,TenPercentOwner | 2024-03-25 | Purchase | 437,600.0 | $9.06 |
| Kolchinsky Peter | Director,TenPercentOwner | 2024-03-25 | Purchase | 437,600.0 | $9.06 |
| Shah Rajeev M. | Director,TenPercentOwner | 2024-03-25 | Purchase | 437,600.0 | $9.06 |
| RA Capital Nexus Fund II, L.P. | Director | 2024-03-25 | Purchase | 437,600.0 | $9.06 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-03-25 | Sale | 47,632.0 | $9.12 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-03-25 | Sale | 47,635.0 | $9.12 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-03-25 | Sale | 47,632.0 | $9.12 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-03-25 | Sale | 47,635.0 | $9.12 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-03-22 | Sale | 1,326.0 | $9.01 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-03-22 | Sale | 1,017.0 | $9.03 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-03-22 | Sale | 1,326.0 | $9.01 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-03-22 | Sale | 1,017.0 | $9.03 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-03-21 | Sale | 100.0 | $9.0 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-03-21 | Sale | 372.0 | $9.0 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-03-21 | Sale | 100.0 | $9.0 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-03-21 | Sale | 372.0 | $9.0 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-03-19 | Sale | 942.0 | $9.04 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-03-19 | Sale | 976.0 | $9.03 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-03-19 | Sale | 942.0 | $9.04 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-03-19 | Sale | 976.0 | $9.03 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-03-15 | Sale | 48,461.0 | $9.14 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-03-15 | Sale | 48,295.0 | $9.14 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-03-15 | Sale | 48,461.0 | $9.14 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-03-15 | Sale | 48,295.0 | $9.14 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-03-14 | Sale | 239.0 | $9.0 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-03-14 | Sale | 205.0 | $9.0 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-03-14 | Sale | 239.0 | $9.0 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-03-14 | Sale | 205.0 | $9.0 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-03-13 | Sale | 1,300.0 | $9.0 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-03-13 | Sale | 1,500.0 | $9.0 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-03-13 | Sale | 1,300.0 | $9.0 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-03-13 | Sale | 1,500.0 | $9.0 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-02-29 | Sale | 1,000.0 | $9.02 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-02-29 | Sale | 1,982.0 | $9.01 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-02-29 | Sale | 800.0 | $9.02 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-02-29 | Sale | 1,000.0 | $9.02 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-02-29 | Sale | 1,982.0 | $9.01 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-02-29 | Sale | 800.0 | $9.02 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-02-28 | Sale | 24,303.0 | $9.02 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-02-28 | Sale | 49,019.0 | $9.02 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-02-28 | Sale | 25,456.0 | $9.02 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-02-28 | Sale | 24,303.0 | $9.02 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-02-28 | Sale | 49,019.0 | $9.02 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-02-28 | Sale | 25,456.0 | $9.02 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-02-26 | Sale | 100.0 | $9.01 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-02-26 | Sale | 500.0 | $9.01 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | 2024-02-26 | Sale | 100.0 | $9.01 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-02-26 | Sale | 100.0 | $9.01 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-02-26 | Sale | 500.0 | $9.01 |
| Lowenthal Richard E | PRESIDENT AND CEO | 2024-02-26 | Sale | 100.0 | $9.01 |
| Fitzpatrick Alexander A | Chief Legal Officer | 2023-09-29 | Purchase | 46,258.0 | $3.78 |
| Fitzpatrick Alexander A | Chief Legal Officer | 2023-09-28 | Purchase | 40,000.0 | $3.62 |
| RA Capital Healthcare Fund LP | Director | 2023-09-21 | Purchase | 191,309.0 | $3.83 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 2023-09-21 | Purchase | 191,309.0 | $3.83 |
| Kolchinsky Peter | Director | 2023-09-21 | Purchase | 191,309.0 | $3.83 |
| Shah Rajeev M. | Director | 2023-09-21 | Purchase | 191,309.0 | $3.83 |
| RA Capital Nexus Fund II, L.P. | Director | 2023-09-21 | Purchase | 191,309.0 | $3.83 |
| RA Capital Healthcare Fund LP | Director | 2023-09-21 | Purchase | 2,508,691.0 | $2.97 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 2023-09-21 | Purchase | 2,508,691.0 | $2.97 |
| Kolchinsky Peter | Director | 2023-09-21 | Purchase | 2,508,691.0 | $2.97 |
| Shah Rajeev M. | Director | 2023-09-21 | Purchase | 2,508,691.0 | $2.97 |
| RA Capital Nexus Fund II, L.P. | Director | 2023-09-21 | Purchase | 2,508,691.0 | $2.97 |
| Shawver Laura | Director | 2023-09-01 | Sale | 100,000.0 | $7.71 |
| RA Capital Healthcare Fund LP | Director | 2023-08-29 | Purchase | 3,750,000.0 | $6.2 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 2023-08-29 | Purchase | 3,750,000.0 | $6.2 |
| Kolchinsky Peter | Director | 2023-08-29 | Purchase | 3,750,000.0 | $6.2 |